Sanofi to acquire Dren Bio’s immunology unit

Sanofi to acquire Dren Bio’s immunology unit

Source: 
Investing.com
snippet: 

Sanofi (NASDAQ:SNY) on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.